Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 29% ± 11% | |
epithelial cell | 5 studies | 34% ± 11% | |
transit amplifying cell | 3 studies | 20% ± 3% | |
adipocyte | 3 studies | 19% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 4 studies | 22% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 11297.59 | 226 / 226 | 100% | 89.82 | 406 / 406 |
pancreas | 100% | 1701.60 | 327 / 328 | 100% | 36.50 | 178 / 178 |
kidney | 100% | 4024.91 | 89 / 89 | 99% | 79.30 | 895 / 901 |
thymus | 100% | 2294.78 | 652 / 653 | 99% | 40.72 | 601 / 605 |
stomach | 100% | 2393.85 | 359 / 359 | 99% | 47.04 | 283 / 286 |
intestine | 100% | 4758.18 | 965 / 966 | 98% | 58.45 | 517 / 527 |
bladder | 100% | 1656.29 | 21 / 21 | 97% | 39.97 | 491 / 504 |
prostate | 99% | 1391.72 | 243 / 245 | 97% | 28.69 | 488 / 502 |
uterus | 97% | 996.08 | 165 / 170 | 98% | 31.36 | 449 / 459 |
esophagus | 98% | 1657.13 | 1423 / 1445 | 95% | 24.07 | 174 / 183 |
lung | 92% | 1326.03 | 533 / 578 | 97% | 30.45 | 1121 / 1155 |
adrenal gland | 100% | 4660.99 | 258 / 258 | 89% | 42.28 | 204 / 230 |
breast | 100% | 3880.02 | 459 / 459 | 85% | 25.23 | 955 / 1118 |
skin | 88% | 1007.22 | 1599 / 1809 | 93% | 36.56 | 440 / 472 |
ovary | 86% | 751.36 | 155 / 180 | 86% | 17.33 | 369 / 430 |
brain | 80% | 917.92 | 2116 / 2642 | 80% | 18.19 | 566 / 705 |
adipose | 100% | 4047.05 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 88.11 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 31.20 | 29 / 29 |
muscle | 100% | 8004.77 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2974.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.53 | 45 / 45 |
heart | 98% | 3738.84 | 846 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 90% | 983.72 | 1202 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 66% | 791.49 | 612 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0046359 | Biological process | butyrate catabolic process |
GO_0033539 | Biological process | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005739 | Cellular component | mitochondrion |
GO_0005634 | Cellular component | nucleus |
GO_0003995 | Molecular function | acyl-CoA dehydrogenase activity |
GO_0004085 | Molecular function | butyryl-CoA dehydrogenase activity |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
Gene name | ACADS |
Protein name | Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase) Short-chain specific acyl-CoA dehydrogenase, mitochondrial (EC 1.3.8.1) (Butyryl-CoA dehydrogenase) |
Synonyms | hCG_27359 |
Description | FUNCTION: Short-chain specific acyl-CoA dehydrogenase is one of the acyl-CoA dehydrogenases that catalyze the first step of mitochondrial fatty acid beta-oxidation, an aerobic process breaking down fatty acids into acetyl-CoA and allowing the production of energy from fats (By similarity). The first step of fatty acid beta-oxidation consists in the removal of one hydrogen from C-2 and C-3 of the straight-chain fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA (By similarity). Among the different mitochondrial acyl-CoA dehydrogenases, short-chain specific acyl-CoA dehydrogenase acts specifically on acyl-CoAs with saturated 4 to 6 carbons long primary chains . . |
Accessions | ENST00000411593.2 P16219 E5KSD5 ENST00000242592.9 E9PE82 D4QEZ8 |